The Emerging Evidence of the Parkinson Pandemic

Effectiveness and costs of specialised physiotherapy given via ParkinsonNet: a retrospective analysis of medical claims data

(2018) Jan H L Ypinga et al.   LANCET NEUROLOGY

The Parkinson Pandemic—A Call to Action

(2018) E. Ray Dorsey et al.   JAMA Neurology

Projections of prevalence, lifetime risk, and life expectancy of Parkinson's disease (2010-2030) in France

(2018) Mathilde Wanneveich et al.   MOVEMENT DISORDERS

Parkinson Matters

(2018) Sirwan K.L. Darweesh et al.   Journal of Parkinsons Disease

Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

(2018) E. Ray Dorsey et al.   LANCET NEUROLOGY

Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

(2017) Valery L Feigin et al.   LANCET NEUROLOGY

Projection of the prevalence of Parkinson's disease in the coming decades: Revisited

(2017) Alexander Rossi et al.   MOVEMENT DISORDERS

Survival and Causes of Death Among People With Clinically Diagnosed Synucleinopathies With Parkinsonism

(2017) Rodolfo Savica et al.   JAMA Neurology

Trends in the Incidence of Parkinson Disease in the General Population

(2016) Sirwan K. L. Darweesh et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

US Spending on Personal Health Care and Public Health, 1996-2013

(2016) Joseph L. Dieleman et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Unchanged long-term rural-to-urban incidence ratio of Parkinson's disease

(2016) Juuso Isotalo et al.   MOVEMENT DISORDERS

Time Trends in the Incidence of Parkinson Disease

(2016) Rodolfo Savica et al.   JAMA Neurology

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition

(2015) Christopher J L Murray et al.   LANCET

Linking Smoking, Coffee, Urate, and Parkinson’s Disease – A Role for Gut Microbiota?

(2015) Filip Scheperjans et al.   Journal of Parkinsons Disease

Time trends of incidence of age-associated diseases in the US elderly population: medicare-based analysis

(2013) I. Akushevich et al.   AGE AND AGEING

Environmental Toxins and Parkinson's Disease

(2013) Samuel M. Goldman   Annual Review of Pharmacology and Toxicology

The current and projected economic burden of Parkinson's disease in the United States

(2013) Stacey L. Kowal et al.   MOVEMENT DISORDERS

What Is a Pandemic?

(2009) David M. Morens et al.   JOURNAL OF INFECTIOUS DISEASES

Incidence and remaining lifetime risk of Parkinson disease in advanced age

(2009) J. A. Driver et al.   NEUROLOGY